BASF is set to strengthen its global operations by establishing a new Global Service Hub in Hyderabad. The move follows a strategic agreement with the Telangana Government, reinforcing the city’s position as a leading business and technology destination. As part of the development, BASF representatives submitted a Letter of Intent (LoI) to Sridhar Babu, Minister for IT, Telangana. The proposal outlines the creation of a new entity, BASF Global Business Services Private Limited, which will anchor the company’s shared services operations in India.

Focus on Finance and HR Excellence

The upcoming Global Service Hub will primarily deliver strategic Finance and Human Resources (HR) services. By centralising these critical functions, BASF aims to enhance operational efficiency, streamline global processes, and support its worldwide business units more effectively. Hyderabad continues to gain prominence as a strategic node within BASF’s global service network. The city’s robust infrastructure, skilled talent pool, and favourable business environment have made it an attractive destination for multinational corporations.

Driving Efficiency Through Global Integration

As reported by thehansindia.com, BASF’s Global Service Hub in Hyderabad marks a significant step toward enhancing its global service delivery model. At the same time, it reinforces India’s growing role as a strategic hub for multinational business operations.

Praj Industries announced the establishment of an Advanced Precision Fermentation Lab at Praj Matrix, marking a significant step toward accelerating next-generation biotechnology and low-carbon biomanufacturing in India. The announcement, made during the 18^th Praj Matrix Foundation Day, underscores the company’s commitment to strengthening India’s bioeconomy through innovation, skill development, and academia–industry collaboration.

Driving Next-Generation Biomanufacturing with AI-Enabled Technologies

The newly launched facility stands out as a globally advanced platform focused on high-capacity, AI-enabled precision fermentation. It aims to improve process efficiency, minimise scale-up risks, and enhance reliability in bioprocessing. The lab will enable Praj and Praj HiPurity Systems to deliver cutting-edge fermentation solutions across industries such as pharmaceuticals, food, cosmetics, biofuels, and beverages.

Strategic Collaboration with BRIC–NCCS

To further strengthen its innovation ecosystem, Praj formalised a Memorandum of Understanding (MoU) with BRIC–NCCS (Biotechnology Research and Innovation Council – National Centre for Cell Science). The partnership integrates Praj’s expertise in process engineering and manufacturing with NCCS’s strengths in microbial research, genomics, and cell culture repositories. As a result, the collaboration will accelerate the journey from scientific discovery to scalable biomanufacturing.

Additionally, the initiative will focus on:

*Developing advanced bioprocessing capabilities

*Discovering high-value biomolecules and microbial strains

*Offering training, internships, and research opportunities for PhD scholars

*Enabling long-term joint research and industry sponsorships

Aligning with India’s BioE3 Vision

The initiative aligns closely with the government’s BioE3 (Biotechnology for Economy, Environment, and Employment) programme, led by the Department of Biotechnology. Rajesh S. Gokhale, Secretary, Department of Biotechnology (DBT), emphasised that strong academia–industry linkages and a skilled scientific workforce will be critical to driving India’s bioeconomy growth. He noted that such collaborations will accelerate innovation and strengthen the country’s bio-based economy.

Integrating Biology, Engineering, and Digital Innovation

Pramod Chaudhari, Founder Chairman of Praj Industries, highlighted that the lab represents a major milestone in the company’s innovation journey. He stated that the facility combines biology, engineering, and digital technologies to create scalable and sustainable solutions. Furthermore, the collaboration with BRIC–NCCS will play a crucial role in talent development and in bridging the gap between research and commercial deployment.

Strengthening India’s Bioeconomy Leadership

The launch of the Advanced Precision Fermentation Lab reinforces Praj Industries’ leadership in industrial biotechnology. As per the press release, by combining advanced research, strategic partnerships, and scalable solutions, the company is well-positioned to drive India’s transition to a globally competitive, low-carbon biomanufacturing ecosystem.

Kiran Mazumdar-Shaw, founder and chairperson of Biocon, has outlined a clear five-year succession plan to ensure a smooth leadership transition. She confirmed that her niece, Claire Mazumdar, is being groomed to eventually take over as chair. Mazumdar-Shaw emphasised that the transition will be gradual and carefully structured. Rather than an immediate change, Claire Mazumdar will move step-by-step through key leadership roles—starting as a director, progressing to vice-chair, and ultimately assuming the position of chair. Mazumdar-Shaw clarified that she will remain actively involved during this period, ensuring continuity and strategic guidance.

From Startup Roots to Global Biopharma Leader

Founded in 1978 in a garage in Bengaluru, Biocon has grown into one of the world’s leading biosimilars manufacturers. Today, the company commands a strong global presence, with significant revenues coming from the United States and European markets. Biocon has developed a robust portfolio of over 30 biosimilars, with 12 already commercialised and several more in the pipeline. These therapies play a critical role in treating complex diseases such as cancer, diabetes, rheumatoid arthritis, and psoriasis.

Strengthening Leadership with Global Biotech Expertise

Claire Mazumdar brings strong scientific and strategic credentials to the role. She is currently the founding CEO of Bicara Therapeutics, an oncology-focused biotech firm. Prior to this, she led business development and corporate strategy at Rheos Medicines and worked with Third Rock Ventures, where she focused on company formation. Additionally, she holds a PhD in cancer biology from Stanford School of Medicine.

Balancing Continuity and Innovation

Mazumdar-Shaw highlighted that Claire’s vision aligns closely with Biocon’s future direction. At the same time, Claire is expected to continue her involvement with Bicara Therapeutics during the transition phase, ensuring continuity across her current responsibilities. With a significant stake in Biocon, Mazumdar-Shaw underscored the importance of maintaining family involvement in the company’s leadership. The structured succession plan reflects a balanced approach—preserving legacy while preparing the organisation for future growth.

A Carefully Managed Leadership Evolution

As reported by reuters.com, Biocon’s planned leadership transition signals stability and long-term strategic clarity. By combining experienced leadership with next-generation expertise, the company is well-positioned to strengthen its global footprint in biosimilars and advanced biopharmaceuticals.

Clariant IGL Specialty Chemicals (CISC) presented its latest portfolio of specialty chemical solutions at the recently concluded ChemExpo 2026 in Mumbai. The company highlighted its strong focus on sustainability, innovation, and customer-centric solutions across multiple industries.

Leadership Perspective: Driving Growth with Sustainable Chemistry

Nitin Sharma, CEO and GM of CISC, emphasized the company’s commitment to green chemistry and regional growth. He noted that CISC is a leading supplier of specialty chemicals, particularly green ethylene oxide derivatives, designed to meet the rapidly increasing demand across South Asia. Furthermore, the company combines global expertise with strong local manufacturing and close customer partnerships to deliver high-performance and sustainable solutions.

Diverse Product Portfolio Supporting Multiple Industries

CISC showcased a comprehensive portfolio that spans a wide range of specialty chemical segments. In addition to its core ethoxylates, the company offers:

*Biocides, surfactants, and pH stabilizers

*Defoamers, emulsifiers, and wetting agents

*Dispersing agents and rheology modifiers

*Emollients, UV filters, and humectants

*Specialty solvents

As a result, CISC effectively supports key industries such as coatings, industrial lubricants, agriculture, textiles, construction, pharmaceuticals, and personal and home care.

Innovation Highlights Across Key Industry Segments

Under the theme “Creating a Sustainable Future with Innovative Solutions,” CISC showcased cutting-edge innovations across seven major segments:

Coatings & Construction

High-performance reactive emulsifiers for polymeric binders: Emulsogen CPA 100XS and Emulsogen CPN 100XS

Crop Solutions

Advanced adjuvant technology to improve soil health: Synergen Soil and Synergen Soil RO5

Home Care

Eco-conscious solutions transforming laundry care: TexCare Gemini Terra

Industrial Lubricants

Polyalkylene glycol-based synthetic oils offering high load capacity and thermal stability: Polyglykol D21 series

Personal Care

Natural emulsifier systems delivering enhanced sensory performance: Plantasens Emulsifier HP 49

Textile

Sustainable and high-performance processing solutions: CBR package for cotton (GOTS/ZDHC certified)

Base Chemicals

Power brands including Castrox, Alphox, Acrodet, Cetodet, Polymeg, Igsurf, and Sorbox

Strong Local Presence Backed by Global Expertise

CISC continues to strengthen its “local-for-local” strategy by investing in regional capabilities. The company operates advanced R&D and technical application facilities in Kashipur and Navi Mumbai, enabling faster response times and customized solutions. Additionally, its manufacturing site in Kashipur, Uttarakhand, supports efficient local production while leveraging Clariant’s global expertise and innovation capabilities.

Innovation and Sustainability at the Core

As per the press release, CISC’s participation at ChemExpo 2026 reinforces its commitment to delivering sustainable, high-performance chemical solutions. By integrating global knowledge with local execution, the company is well-positioned to meet evolving industry demands and drive innovation across sectors.

India is stepping up efforts to expand its liquefied natural gas (LNG) storage capacity in response to supply disruptions triggered by the ongoing geopolitical conflict in West Asia. The move highlights the country’s growing focus on strengthening energy security and ensuring supply stability.

Strategic Push Led by Petronet LNG Ltd

According to the leadership at Petronet LNG Ltd, India’s largest gas importer, enhancing LNG storage infrastructure has become an urgent priority. As global uncertainties rise, the company is actively planning capacity expansion to safeguard against supply shocks. To reinforce its storage capabilities, Petronet LNG has outlined a series of infrastructure projects across multiple locations:

*Two new LNG storage tanks at Gopalpur, Odisha

*One additional tank at Kochi, Kerala

*Expanded storage capacity at Dahej, Gujarat

These projects are expected to be completed within the next three years. Once operational, they will significantly strengthen India’s ability to maintain uninterrupted gas supply even during periods of global disruption.

Geopolitical Tensions Disrupt LNG Supplies

The expansion plans come at a critical time, as LNG imports from Qatar have been impacted due to escalating geopolitical tensions in West Asia. Given that LNG accounts for a substantial share of India’s energy mix, such disruptions expose vulnerabilities in the country’s energy supply chain.

Strengthening Energy Security Through Strategic Reserves

India is prioritising the development of strategic LNG reserves. By increasing storage capacity, the country aims to build a buffer against future supply uncertainties and price volatility. Moreover, enhanced storage infrastructure will enable better demand management, improve supply flexibility, and reduce dependence on immediate imports during crises.

Building a Resilient Energy Future

As reported by devdisvourse.com, India’s proactive approach to expanding LNG storage reflects a broader strategy to build a resilient and secure energy ecosystem. As global energy markets remain volatile, investments in infrastructure and diversification will play a crucial role in ensuring long-term stability.

India’s pharmaceutical exports continued to demonstrate strong resilience in FY26, surpassing ₹2.86 lakh crore. Despite facing global headwinds such as pricing pressures, regulatory complexities, and geopolitical uncertainties, the sector maintained steady growth and reinforced its global standing. India has consistently positioned itself as a reliable supplier of affordable, high-quality medicines worldwide. This strength stems from its robust manufacturing infrastructure and diversified export base.

Key export segments include generic formulations, bulk drugs (APIs), vaccines, and biosimilars. Meanwhile, major markets such as the United States, Europe, Africa, and several emerging economies continue to drive demand, ensuring balanced and sustained export performance.

Competitive Edge Drives Sustained Growth

The pharmaceutical sector benefits from a strong competitive advantage in cost-efficient production and stringent regulatory compliance. As a result, Indian companies continue to meet global quality standards while maintaining affordability. Rising global demand for high-quality generics and the industry’s expansion into complex therapies have significantly contributed to export growth. At the same time, improvements in domestic pharmaceutical infrastructure have further strengthened production capabilities.

Policy Support and Industry Initiatives Boost Momentum

Government initiatives have played a crucial role in accelerating growth. Notably, the Production Linked Incentive (PLI) scheme for pharmaceuticals and bulk drugs has encouraged domestic manufacturing and reduced reliance on imports. In addition, Indian pharmaceutical companies are actively investing in research and development, securing regulatory approvals, and diversifying product portfolios. These efforts are helping the industry tap into high-value and regulated markets more effectively.

Rising Investments in Advanced Therapies

The sector is also witnessing increased investments in biotechnology, biosimilars, and specialty drugs. Consequently, India is steadily moving up the value chain and strengthening its global competitiveness in advanced pharmaceutical segments. India’s pharmaceutical industry is well-positioned to sustain its growth trajectory. Innovation, regulatory alignment, and expanding global healthcare demand will continue to act as key growth drivers. Moreover, a strategic focus on emerging markets, value-added products, and supply chain resilience will further enhance export potential.

A Key Pillar of Global Healthcare

As reported by ibef.org, India’s strong export performance in FY26 underscores its critical role in the global pharmaceutical landscape. By consistently delivering affordable and high-quality medicines, the country continues to expand access to healthcare worldwide while reinforcing its position as a trusted global pharma hub.

Safic-Alcan, a global distributor of specialty chemicals, announced the acquisition of a majority stake in S.A. Ingredients Private Limited (SAI). The strategic move strengthens Safic-Alcan’s presence in India’s rapidly growing pharmaceutical and nutraceutical sectors. S.A. Ingredients was established in September 2023 following the demerger of the distribution business from S.A. Pharmachem Private Limited (SAP), a Mumbai-headquartered company with operations dating back to 1992. SAI serves more than 400 customers across the pharmaceutical and nutraceutical industries. Moreover, the company collaborates with globally reputed principals and operates with a team of over 30 professionals, ensuring consistent service and technical expertise.

Strategic Expansion in Asia and Life Sciences

Commenting on the acquisition, Yann Lissillour, CEO of Safic-Alcan Group, emphasized that the deal aligns with the company’s long-term growth strategy in Asia. He noted that India’s strong GDP growth and expanding healthcare sector make it a critical market for future expansion. Additionally, S.A. Ingredients brings complementary capabilities, particularly in probiotics, pharmaceutical excipients, and nutraceutical ingredients. Importantly, the acquisition also builds on Safic-Alcan’s recent investment in Avees Biocos, further strengthening its Life Sciences platform in the region.

Capitalising on High-Growth Market Opportunities

Laurent Nataf, Managing Director – M&A at Safic-Alcan Group, highlighted the strong growth potential of the probiotics segment, which is projected to grow at around 20% annually. He added that S.A. Ingredients is well-positioned to capitalise on this opportunity due to its long-standing relationships with key principals. As a result, the combined entity will be able to deliver more specialised solutions and enhanced services to both customers and partners.

Leadership Perspective: Growth with Continuity

Gaurav Kabra, Managing Director of S.A. Ingredients, stated that joining Safic-Alcan will accelerate the company’s growth trajectory. He further emphasized that the partnership provides access to a global network, advanced resources, and industry expertise. At the same time, the company will continue to uphold its strong service commitment and operational continuity built over decades.

Strengthening India’s Role in Global Life Sciences

As per the press release, the acquisition marks a significant step in Safic-Alcan’s strategy to expand its footprint in India and the Asia-Pacific region. By combining global capabilities with strong local expertise, the company is well-positioned to tap into the growing demand for specialty ingredients in pharmaceuticals and nutraceuticals.

Solex Energy Ltd is set to transform India’s clean energy landscape after signing a landmark Memorandum of Understanding (MoU) with the Government of Gujarat. With a planned investment of ₹4,000 crore, the company aims to develop a massive integrated renewable energy manufacturing ecosystem, driving both industrial innovation and massive job creation in the region.

Building an Integrated Renewable Manufacturing Ecosystem

Solex Energy will build a comprehensive manufacturing hub that bridges the gap between solar production and energy storage. By integrating these two sectors, the project will solidify Gujarat’s status as India’s premier renewable energy powerhouse. Furthermore, the initiative seeks to create a seamless industrial value chain, fostering synergies across various clean energy technologies.

Phased Expansion of Solar Cell Capacity

A core component of the project is the establishment of a 5 GW solar cell manufacturing facility. To ensure operational efficiency and stay ahead of technological trends, Solex will execute the expansion in two distinct phases:

Phase 1: Launching with a 2 GW capacity.

Phase 2: Scaling up with an additional 3 GW capacity.

The phased strategy enables the company to scale its operations responsibly while remaining agile in a fluctuating global market.

Strategic Entry into BESS

Beyond solar generation, Solex Energy is making a bold move into the energy storage market by establishing a 10 GW Battery Energy Storage System (BESS) manufacturing unit. Consequently, this expansion allows Solex to control both the generation and the storage aspects of the energy cycle. This dual-focus is vital for modernizing India’s power infrastructure and ensuring grid stability.

Championing India’s Self-Reliance in Clean Energy

This ₹4,000 crore investment significantly boosts domestic manufacturing, directly reducing India’s reliance on imported green technologies. As a result, the project aligns perfectly with national “Atmanirbhar Bharat” goals. Simultaneously, the facility will accelerate Gujarat’s contributions to the national transition toward a net-zero future.

Leadership Vision: Driving Long-Term Growth

Chetan Shah, representing Solex Energy, emphasized that the integrated ecosystem is designed for long-term sustainability. He noted that moving into advanced solar cell production and high-capacity storage is essential for meeting the world’s skyrocketing energy demands.

A Future-Ready Position in Solar and Storage

As global demand for decarbonization accelerates, the synergy between solar power and battery storage becomes increasingly critical. As reported by businessworld.in, by investing heavily in both segments, Solex Energy is not just expanding its footprint; it is strategically positioning itself to lead the next generation of the renewable energy revolution.

Meghmani Organics received regulatory approval from the Ministry of Agriculture and Farmers Welfare to manufacture nano fertiliser products through its wholly owned subsidiary, Meghmani Crop Nutrition Limited. The approval marks a significant step in the company’s strategy to expand its advanced crop nutrition portfolio.

Approval Covers Key Nano Fertiliser Products

The regulatory clearance includes three major nano fertiliser products:

Nano DAP

Nano NPK

Nano Zinc

The products are designed to enhance nutrient efficiency and address evolving agricultural needs. As a result, Meghmani Organics aims to strengthen its presence across multiple nutrient categories while supporting sustainable farming practices.

Manufacturing at Sanand Facility with No Additional Capex

Meghmani Crop Nutrition Limited will manufacture the approved nano fertilisers at its existing facility in Sanand, Gujarat. Notably, the company will leverage current infrastructure, eliminating the need for additional capital expenditure. The approach enables faster scale-up and efficient resource utilization. Commercial production is expected to begin in the upcoming Kharif season, allowing the company to quickly tap into seasonal demand.

Strengthening Crop Nutrition Portfolio

With this development, Meghmani Organics continues to advance its focus on next-generation agricultural inputs. The addition of nano fertilisers is expected to enhance the company’s ability to serve farmers with more efficient and targeted nutrition solutions. The products offer several advantages, including improved nutrient uptake, reduced wastage, and better crop yields—key factors driving adoption in modern agriculture.

Management Commentary

Ankit Patel, Chairman and Managing Director highlighted the strategic importance of the approval. He stated that nano fertilisers represent the future of sustainable agriculture, enabling higher efficiency and improved productivity. He further emphasized that the new product additions will strengthen the company’s market position while reinforcing its commitment to delivering innovative and sustainable crop nutrition solutions.

Outlook: Driving Growth Through Innovation

As reported by scanx.trade, the approval positions Meghmani Organics to capitalize on the growing demand for advanced fertilisers in India. By integrating nano technology into its portfolio, the company is aligning itself with the broader shift toward precision agriculture and sustainable farming practices. As demand for efficient nutrient solutions rises, Meghmani is well-placed to deliver long-term value to both farmers and stakeholders.

Axis Energy Ventures is preparing to enter the underground coal gasification (UCG) segment and is close to acquiring critical technology for the initiative. Chairman and Managing Director Kataru Ravi Kumar Reddy confirmed that the company is “about to acquire” the required technology, signalling a major strategic diversification beyond renewables.

Secures Coal Blocks for UCG Development

Axis Energy recently emerged as one of the winners in the coal block allocation for UCG projects. The Ministry of Coal awarded Axis Energy two coal blocks—the dip extension of Belpahar and Tangardihi East mines located in Odisha. These “dip extension” zones represent deeper sections of existing mines where conventional coal extraction is not economically viable. Therefore, converting coal into gas through UCG offers a practical alternative.

Technology Acquisition to Drive Execution

Although Axis Energy has limited prior experience in underground coal gasification, the company is relying on advanced technology acquisition to bridge the gap. While details of the technology remain confidential, Reddy expressed strong confidence in its effectiveness. He added that the company expects gas production from these mines to begin within the next 2–3 years, indicating a relatively fast-track implementation plan.

Strong Renewable Portfolio Supports Expansion

Axis Energy, backed by Brookfield Asset Management, is already a major player in renewable energy. The company currently operates 1.5 GW of commissioned wind and solar projects, has 8 GW under development, and a robust pipeline of 30 GW. Axis has formed joint ventures with Brookfield to execute multiple large-scale energy projects, strengthening its financial and operational capabilities.

₹30,000 Crore Investment Planned for UCG Projects

UCG projects are capital-intensive, and Axis Energy is planning to invest approximately ₹30,000 crore in this venture. Reddy described underground coal gasification as “the need of the hour,” particularly in the context of India’s growing energy demand.

The company plans to utilize the produced gas for multiple applications, including:

*Power generation to meet peak electricity demand

*Ammonia production for industrial use

*Learning from Past Coal Gasification Projects

India’s experience with coal gasification has been mixed. For instance, the Talcher project—developed by Coal India, GAIL, Rashtriya Chemicals and Fertilizers, and Fertilizer Corporation of India—was conceived in 2007, with a joint venture formed in 2015. However, the project is still under development. Underground coal gasification is even more complex than surface gasification, making execution a key challenge.

Government Push for Advanced Coal Technologies

Despite the challenges, the Ministry of Coal remains optimistic about UCG’s potential. The ministry highlighted that the technology can unlock energy from deep or otherwise unworkable coal seams, significantly expanding India’s usable energy resources. By incorporating UCG into coal block auctions, the government aims to future-proof mining assets. This approach enables operators to adopt cleaner and more efficient energy production methods alongside conventional mining.

Outlook: A High-Risk, High-Reward Energy Bet

With strong backing, ambitious investment plans, and upcoming technology acquisition, Axis Energy is positioning itself at the forefront of advanced coal utilization. As reported by thehindubusinessline.com, if successfully executed, the project could not only diversify the company’s energy portfolio but also contribute to India’s evolving energy mix by tapping previously inaccessible coal reserves.